Pharmarise Holdings Corporation
ファーマライズホールディングス株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 2796
FY2025 (May 2026) · J-GAAP · consolidated Source: filing S100YXWI
FY = fiscal year, named by the calendar year it starts in; the month in brackets is when it ends (FY2025 ends Mar 2026 for a March year-end). FY2025 (May 2026) runs Jun 1, 2025 – May 31, 2026.
| Gross margin | 13.6% |
|---|---|
| Operating margin | 1.4% |
| Net margin | 0.2% |
| Return on equity | 1.7%Includes one-off items (e.g. gains on negative goodwill) |
| Return on assets | 0.4% |
| Revenue growth (YoY) | 9.5% |
| EPS (basic) | ¥10.01 |
| EPS growth (YoY) | —Base is zero or negative |
| Current ratio | 0.94x |
| Equity ratio | 20.3% |
| Book value / share | ¥576.71 |
| Free cash flow | ¥2.6B |